跳至主要内容
临床试验/CTRI/2024/04/065095
CTRI/2024/04/065095招募中不适用

Microfluidics for IUI to improve outcomes A comparative study in an Indian context

Oasis Fertility1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Clinical pregnancy rates

研究概览

简要总结

Intra uterine insemination is one of the most basic treatments offered to an infertile couple before any complex treatments like In-Vitro Fertilization (IVF)/ Intra-Cytoplasmic Sperm Injection (ICSI)

A number of factors determine the success of an IUI cycle, age of couple, duration of infertility, ovarian reserve and sperm parameters.

Total motile sperm count of the male partner is the most important prognostic factor determining the success of IUI treatment

The swim Up and density gradient method are frequently used to isolate the motile sperms from a raw sample of semen which can be inseminated into the uterus.

Although these methods help in isolating the motile sperms the clinical pregnancy rates with these methods is not more than 10-12 % and also there is a concern about the potential harmful effects on the natural properties of the sperm as these methods involve repeated centrifugation, and high-pressure forces being applied. Moreover, they are time consuming, and outcomes depend on the skill of the technician.

Micro fluidics is a cutting-edge technology which has proven benefits for sperm selection with greater DNA integrity in IVF/ICSI cycles simply because it is a much milder and efficient way to select the sperm based on its properties that of size and motility. The method takes a shorter time and is independent of the technician skills.

While there are multiple studies for Micro fluidics being used for IVF its benefit on IUI has not be

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • Normal Tubes and Uterus.

排除标准

  • Severe Male Factor Cases.

结局指标

主要结局

Clinical pregnancy rates

时间窗: 6 weeks post ovulation

次要结局

  • Miscarriage(6-12 weeks post ovulation)

研究者

发起方
Oasis Fertility
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Krishna Chaitanya Mantravadi

Oasis Fertility

研究点 (1)

Loading locations...

相似试验